Figure 3b). However, subgroup analysis based on cancer type revealed that elevated CTGF expression was a strong prognostic factor for poor DFS in patients with HCC (HR = 1.90, 95% CI: 1.38-2.62) (Figure 4(b)). This evidence concerns the gene CCN2 and hepatocellular carcinoma.